Exec Chat: Medtronic CMO On How COVID-19 Has Changed The Company – And Where It’s Headed
In an exclusive Q&A with Medtech Insight, Medtronic’s Robert Kowal talks about how COVID-19 has pushed the company to focus on remote capabilities for their cardiac devices, permanently changed its corporate culture, and more.
You may also be interested in...
It is time for In Vivo's 13th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.
The document from the Medical Device Innovation Consortium aggregates external data sources, various statistical methods and lays out other considerations for sponsors to help speed up and bolster a premarket product application to the US FDA.
A top executive at the Swedish company spoke with Medtech Insight about how the mobility and data reliability of 5G cellular technology will change how medtech manufacturers design their products.